Skip to main content

Bristol Myers Squibb balance sheet

  • BMY · NYSE
  • Pharmaceuticals
  • S&P 500
$63.43+1.78%Close 13 Nov 2026 · Market value $128.9B

At the end of fiscal 2025 (the year to 31 Dec 2025), Bristol Myers Squibb reported total assets of $90.04B, $10.21B in cash and equivalents, $49.12B of total debt; shareholders' equity was $18.47B.

From Bristol Myers Squibb's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025.

Annual

Bristol Myers Squibb balance sheet, annual
USDFY 2007FY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Cash and equivalents$1.80B$7.98B$7.68B$5.03B$5.78B$1.66B$3.59B$5.57B$2.38B$4.24B$5.42B$6.91B$12.35B$14.55B$13.98B$9.12B$11.46B$10.35B$10.21B
Short-term investments—$289.0M$831.0M$2.27B$2.96B$1.17B$939.0M$1.86B$1.89B$2.11B$1.39B$1.85B$3.05B$1.28B$2.99B$130.0M$816.0M$513.0M$464.0M
Cash and short-term investments$1.80B$8.27B$8.51B$7.30B$8.73B$2.83B$4.53B$7.43B$4.27B$6.35B$6.81B$8.76B$15.39B$15.83B$16.97B$9.25B$12.28B$10.86B$10.67B
Accounts receivable——$1.90B$1.99B$2.25B$1.71B$1.69B$2.10B$2.95B$3.77B$4.35B$4.64B$6.48B$7.22B$7.98B$8.15B$8.88B$9.01B$9.59B
Inventory—$1.76B$1.41B$1.20B$1.38B$1.66B$1.50B$1.56B$1.22B$1.24B$1.17B$1.20B$4.29B$2.07B$2.10B$2.34B$2.66B$2.56B$2.69B
Current assets—$14.70B$13.96B$13.27B$15.32B$9.52B$18.92B$14.61B$10.41B$13.70B$14.85B$17.72B$29.35B$30.19B$33.26B$27.27B$31.77B$29.78B$29.39B
Property, plant and equipment—$5.41B$5.05B$4.66B$4.52B$5.33B$4.58B$4.42B$4.41B$4.98B$5.00B$5.03B$6.25B$5.89B$6.05B$6.25B$6.65B$7.14B$7.54B
Goodwill—$4.83B$5.22B$5.23B$5.59B$7.63B$7.10B$7.03B$6.88B$6.88B$6.86B$6.54B$22.49B$20.55B$20.50B$21.15B$21.17B$21.72B$21.75B
Acquired intangibles$1.33B$1.15B$2.87B$3.37B$3.12B$8.78B$2.32B$1.75B$1.42B$1.39B$1.21B$1.09B$63.97B$53.24B$42.53B$35.86B$27.07B$23.31B$19.10B
Long-term investments—$188.0M$1.37B$2.68B$2.91B$3.52B$3.75B$4.41B$4.66B$2.72B$2.48B$1.77B$767.0M$433.0M$0.00————
Total assets—$29.49B$31.01B$31.08B$32.97B$35.90B$38.59B$33.75B$31.75B$33.71B$33.55B$34.99B$129.9B$118.5B$109.3B$96.82B$95.16B$92.60B$90.04B
Accounts payable—$1.53B$1.71B$1.98B$2.60B$2.20B$2.56B$2.49B$1.56B$1.66B$2.25B$1.89B$2.44B$2.71B$2.95B$3.04B$3.26B$3.60B$3.58B
Unearned revenue, current—$277.0M$237.0M————————————————
Short-term borrowings—$154.0M$231.0M$117.0M$115.0M$826.0M$359.0M$590.0M$139.0M$109.0M$987.0M$1.70B$3.35B$2.34B$4.95B$4.26B$3.12B$2.05B$2.26B
Long-term debt · current portion—————$664.0M$27.00M$590.0M$139.0M$749.0M$0.00$1.25B$2.76B$2.00B$4.76B$3.90B$2.87B$1.83B$1.98B
Current liabilities—$6.71B$6.31B$6.74B$7.78B$8.28B$12.44B$8.46B$8.02B$8.84B$9.56B$10.65B$18.30B$19.08B$21.87B$21.89B$22.26B$23.77B$23.42B
Long-term debt · non-current—$6.58B$6.13B$5.33B$5.38B$6.57B$7.98B$7.24B$6.55B$5.72B$6.97B$5.65B$43.39B$48.34B$39.60B$35.06B$36.65B$47.60B$42.85B
Operating lease liability————————————$805.0M$997.0M$1.04B$1.40B$1.69B$1.55B$2.03B
Total liabilities—$17.28B$16.22B$15.44B$17.10B$22.26B$23.36B$18.77B$17.32B$17.36B$21.70B$20.86B$78.25B$80.60B$73.31B$65.70B$65.67B$76.22B$71.53B
Retained earnings$19.76B$22.55B$30.76B$31.64B$33.07B$32.73B$32.95B$32.54B$31.61B$33.51B$31.16B$34.06B$34.47B$21.28B$23.82B$25.50B$28.77B$14.91B$16.90B
Minority interest—−$33.00M$58.00M−$75.00M−$89.00M$15.00M$82.00M$131.0M$158.0M$170.0M$106.0M$96.00M$100.0M$60.00M$60.00M$57.00M$55.00M$53.00M$33.00M
Shareholders' equity—$12.24B$14.84B$15.71B$15.96B$13.62B$15.15B$14.85B$14.27B$16.18B$11.74B$14.03B$51.60B$37.82B$35.95B$31.06B$29.43B$16.34B$18.47B
Total liabilities and equity—$29.49B$31.01B$31.08B$32.97B$35.90B$38.59B$33.75B$31.75B$33.71B$33.55B$34.99B$129.9B$118.5B$109.3B$96.82B$95.16B$92.60B$90.04B
Total debt—$6.74B$6.36B$5.45B$5.49B$8.06B$8.37B$7.83B$6.69B$6.57B$7.96B$8.60B$50.30B$53.67B$50.36B$44.61B$44.34B$53.03B$49.12B
Net debt—−$1.53B−$2.15B−$1.86B−$3.24B$5.23B$3.84B$397.0M$2.42B$224.0M$1.15B−$161.0M$34.91B$37.84B$33.39B$35.36B$32.06B$42.17B$38.44B
Net working capital—$11.00M−$38.00M$1.50B$1.76B−$414.0M$2.89B$576.0M$13.00M$626.0M−$130.0M$151.0M−$1.30B−$3.43B−$2.58B−$3.74B−$1.96B−$4.34B−$4.24B
Shares outstanding · period end——1.7B1.7B1.7B—1.7B1.7B1.7B1.7B1.6B1.6B2.3B2.2B2.2B2.1B2.0B2.0B2.0B

Quarterly

Bristol Myers Squibb balance sheet, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Cash and equivalents$11.46B$9.33B$6.29B$7.89B$10.35B$10.88B$12.60B$15.73B$10.21B$9.57B$8.72B$9.57B
Short-term investments$816.0M$340.0M$360.0M$204.0M$513.0M$907.0M$1.00B$776.0M$464.0M$912.0M$2.35B$3.01B
Cash and short-term investments$12.28B$9.67B$6.65B$8.09B$10.86B$11.78B$13.60B$16.50B$10.67B$10.49B$11.07B$12.58B
Accounts receivable$8.88B$8.83B$9.75B$9.32B$9.01B$9.06B$9.71B$9.62B$9.59B$7.95B$9.08B$9.19B
Inventory$2.66B$2.98B$3.08B$3.33B$2.56B$2.67B$2.74B$2.76B$2.69B$2.76B$2.74B$2.70B
Current assets$31.77B$28.67B$26.89B$28.07B$29.78B$30.78B$33.22B$35.63B$29.39B$27.21B$28.58B$29.77B
Property, plant and equipment$6.65B$6.75B$6.84B$6.90B$7.14B$7.21B$7.37B$7.35B$7.54B$7.66B$7.79B$7.97B
Goodwill$21.17B$21.74B$21.73B$21.75B$21.72B$21.74B$21.78B$21.75B$21.75B$21.74B$21.74B$21.73B
Acquired intangibles$27.07B$32.76B$29.43B$26.96B$23.31B$22.49B$21.38B$20.46B$19.10B$18.24B$17.39B$16.94B
Total assets$95.16B$99.03B$94.65B$93.67B$92.60B$92.43B$94.68B$96.89B$90.04B$86.48B$87.63B$88.77B
Accounts payable$3.26B$3.54B$3.75B$3.47B$3.60B$4.00B$5.43B$4.29B$3.58B$4.23B$4.16B$4.63B
Short-term borrowings$3.12B$6.19B$3.53B$1.08B$2.05B$3.55B$4.71B$4.51B$2.26B$2.31B$1.03B$1.03B
Long-term debt · current portion$2.87B$2.87B$3.09B$873.0M$1.83B$3.35B$4.47B$4.25B$1.98B$1.99B$768.0M$768.0M
Current liabilities$22.26B$25.82B$23.27B$22.64B$23.77B$24.07B$27.53B$28.14B$23.42B$19.16B$18.66B$18.75B
Long-term debt · non-current$36.65B$49.49B$48.86B$48.67B$47.60B$46.16B$44.47B$44.47B$42.85B$42.15B$42.09B$41.85B
Operating lease liability$1.69B———$1.55B———$2.03B———
Total liabilities$65.67B$82.48B$77.58B$76.47B$76.22B$74.98B$77.19B$78.29B$71.53B$66.37B$65.31B$65.37B
Retained earnings$28.77B$15.64B$16.10B$16.10B$14.91B$16.11B$16.15B$17.09B$16.90B$18.29B$20.32B$21.19B
Minority interest$55.00M$58.00M$54.00M$58.00M$53.00M$59.00M$54.00M$48.00M$33.00M$34.00M$0.00$0.00
Shareholders' equity$29.43B$16.49B$17.02B$17.14B$16.34B$17.39B$17.43B$18.55B$18.47B$20.07B$22.32B$23.40B
Total liabilities and equity$95.16B$99.03B$94.65B$93.67B$92.60B$92.43B$94.68B$96.89B$90.04B$86.48B$87.63B$88.77B
Total debt$44.34B$60.28B$57.10B$52.27B$53.03B$54.59B$55.40B$55.29B$49.12B$48.42B$45.82B$45.58B
Net debt$32.06B$50.61B$50.44B$44.18B$42.17B$42.81B$41.80B$38.79B$38.44B$37.93B$34.75B$33.00B
Net working capital−$1.96B−$6.48B−$2.67B−$2.45B−$4.34B−$4.16B−$6.91B−$8.23B−$4.24B−$1.52B$1.20B$1.44B
Shares outstanding · period end2.0B2.0B2.0B2.0B2.0B2.0B2.0B2.0B2.0B2.0B2.0B2.0B

The main figures as JSON and plain text. See data and methodology.

BMY in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.